Craig Eagle joins corporate advisory board at Provectus
KNOXVILLE, Tenn. — The VP strategic alliances and partnerships for Pfizer’s oncology division has joined the corporate advisory board at a development-stage oncology and dermatology biopharmaceutical company.
Provectus Pharmaceuticals said that the company will benefit from Craig Eagle’s "vast experience in drug development" as the drug maker seeks to commercialize its cancer and dermatological therapies.
Provectus is seeking approval for its novel cancer drug, PV-10, in Australia, and is slated to design a global phase-3 trial for PV-10 as a treatment for metastatic melanoma.
Sagent names new CFO
SCHAUMBURG, Ill. — Jonathon Singer has been appointed CFO of Sagent Pharmaceuticals, the generic drug maker said.
Singer joins Sagent from Landauer, a leader in radiation sciences and services, where he served as SVP finance and CFO. Meanwhile, Sagent’s current CFO, Ron Pauli, will be transitioned into a newly created role of chief business officer, where he will be responsible for product launch execution, product pipeline management and business development.
The transitions are expected to be completed by next month. Both Singer and Pauli will report to Sagent’s CEO Jeffrey Yordon.
NCPA objects to planned Florida expansion of Medicaid pilot program
ALEXANDRIA, Va. — The National Community Pharmacists Association on Monday urged the federal government to reject Florida’s request to extend and expand its Medicaid managed care pilot program statewide from five to 67 counties.
“We understand Florida’s budget crunch and the need to rein Medicaid costs. But if the past is prologue, then expanding Florida’s Medicaid managed care pilot program statewide would be a mistake,” stated Douglas Hoey, EVP and CEO. “For those who would dismiss our concerns about Medicaid managed care, consider the independent study from Georgetown University Health Policy Institute. It revealed that Florida’s five-year old pilot program hasn’t produced verifiable costs savings and has caused significant disruptions to beneficiary access and patient-provider relationships.”
To read the NCPA letter addressing Cindy Mann, director Center for Medicaid and State Operations of the Centers for Medicare and Medicaid Services, click here.
For a copy of the Georgetown University Health Policy Institute referenced by NCPA, click here.